In that study, TIGIT expression was increased on the AD patients’ CD4+ T cells to impede chronic skin inflammation, and TIGIT expression may be impaired in some AD patients, leading to the deterioration of skin inflammation (77, 195). Here, CD4 is linked to dermatitis.